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ABSTRACT
The throughput of DNA reading (sequencing)
has dramatically increased recently due to the
incorporation of in vitro clonal amplification. The
throughput of DNA writing (synthesis) is trailing
behind, with cloning and sequencing constituting
the main bottleneck. To overcome this bottleneck,
an in vitro alternative for in vivo DNA cloning must
be integrated into DNA synthesis methods. Here we
show how a new single molecule PCR (smPCR)-
based procedure can be employed as a general sub-
stitute to in vivo cloning thereby allowing for the first
time in vitro DNA synthesis. We integrated this rapid
and high fidelity in vitro procedure into our earlier
recursive DNA synthesis and error correction pro-
cedure and used it to efficiently construct and
error-correct a 1.8-kb DNA molecule from synthetic
unpurified oligos completely in vitro. Although we
demonstrate incorporating smPCR in a particular
method, the approach is general and can be used
in principle in conjunction with other DNA synthesis
methods as well.
INTRODUCTION
The broad availability of synthetic DNA oligonucleotides
enabled the development of many powerful applications
in biotechnology. Longer synthetic DNA molecules and
libraries (made by the assembly of these oligonucleotides)
in the 0.5–5kb range are now becoming increasingly avail-
able thanks to newly developed synthesis and error correc-
tion methods (1–7). Broad availability of such molecules,
much needed since the advent of synthetic biology and
modern genetic engineering, is expected to enable routine
creation of new genetic material as well as oﬀer an alter-
native to obtaining DNA from natural sources.
Unfortunately, the synthetic DNA oligonucleotides
used as building blocks for making the longer constructs
are error prone. Such errors accumulate linearly with the
length of the constructed molecule and result in an
exponential decrease in the fraction of error-free mole-
cules (Supplementary Figure 1). Hence an exponentially
increasing number of molecules have to be screened, i.e.
cloned into a host organism and sequenced, in order to
obtain ever longer error-free molecules (Supplementary
Figure 2, blue and green plots). In order to mitigate this
eﬀect a two-step assembly process (4,7) is often used,
in which fragments in the 500–1000bp range are ﬁrst
screened via cloning and sequencing and then synthesis
proceeds from the error-free clones (Supplementary
Figure 2, red plot).
In vivo cloning (1–7) is time consuming, manual-
labor intensive, diﬃcult to scale up and automate. This
combined with the sheer number of clones that need to
be screened to obtain long error-free synthetic DNA
(Supplementary Figure 2) makes the cloning phase a bot-
tleneck in de novo DNA synthesis and prevents synthetic
DNA from being routinely produced in a fast, cheap
and high-throughput manner. Reducing the number of
clones required to obtain an error-free molecule is the
subject of intensive ongoing research (1,2,4,6), also
recently addressed by us (5) with a method that relieves
much of this burden (Supplementary Figure 2, cyan plot).
In this report we address the second major issue, namely
replacing the time consuming and labor intensive in vivo
cloning procedure associated with synthetic DNA synth-
esis with a faster and less laborious in vitro cloning
procedure.
Since its introduction, PCR (8) has been implemented in
a myriad of variations, one of which is PCR on a single
DNA template molecule (9), which essentially creates a
PCR ‘clone’. Single molecule PCR (smPCR) is a faster,
cheaper, scalable and automatable alternative to tradi-
tional in vivo cloning. Its standard application in mole-
cular biology has been nonsystematic, most commonly
for the ampliﬁcation of single molecules for sequencing,
genotyping or downstream translation purposes (8–12).
Recently, it has been systematically integrated into high-
throughput DNA reading (sequencing) (13,14). High-
throughput DNA writing (synthesis) technology can also
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reported here. The use of smPCR is described in the
context of our recently introduced DNA synthesis proce-
dure (5), which combines recursive synthesis and error-
correction, and operates as follows. Divide and Conquer
(D&C), the quintessential recursive problem solving tech-
nique, is used in silico to divide the target DNA sequence
to be constructed into fragments short enough to be
synthesized by conventional oligo synthesis, albeit with
errors (15); these oligos are synthesized and are recursively
combined in vitro, forming target DNA molecules with
roughly the same error rate as the source oligos; error-
free parts of these molecules identiﬁed by cloning and
sequencing are extracted and used as new, typically
longer and more accurate inputs to another iteration of
the recursive synthesis procedure. Typically, an error-free
clone is obtained after one iteration of this procedure.
In this article we show that in vitro cloning based on
smPCR can be used as a practical alternative to conven-
tional in vivo cloning in our DNA synthesis protocol.
In particular, we successfully constructed a 1.8-kb long
DNA molecule from synthetic unpuriﬁed oligos using
our recursive synthesis and error correction procedure
with smPCR, and as a control also constructed the same
molecule using conventional in vivo cloning. The results
are compared below.
We expect that our methods may be used to incorporate
smPCR also in other DNA synthesis procedures, for
example in conjunction with the widely used two step
assembly PCR method (7) (Figure 1b).
MATERIALS AND METHODS
Cloning
Fragments were cloned into the pGEM T easy Vector
System1 from PROMEGA. Vectors containing cloned
fragments were transformed into JM109 competent cells
from PROMEGA1 and sequenced.
smPCR
smPCR was performed with hot-start Accusure (BioLINE,
Taunton, MA, USA) for the longer Mitochondrial and
with Taq Polymerase (ABgene, Epsom, United Kingdom)
for the GFP fragment. Template concentration is accord-
ing to calculations described in the paper and dissolved
in 5ml DDW; 10pmol of the CA primer dissolved in
10ml DDW. Reaction contained 25mM TAPS pH 9.3 at
258C,2mMMgCl2,50mMKCl,1mMb-mercaptoethanol,
200mM each of dNTP, 1.9U AccuSure DNA Polymerase
(BioLINE).
Real-time PCR (RT-PCR) Thermal Cycler program:
Enzyme activation at 958C for 10min, denaturation 958C
30s, annealing at Tm of primers 30s, extension 728C
1.5min/kb, 50 cycles. It is important that the PCR is
prepared in a sterile environment using sterile equipment
and uncontaminated reagents.
Methodsfor recursive construction anderror correction
The core recursive construction and reconstruction
(error-correction) step requires four basic enzymatic
reactions: phosphorylation, elongation, PCR and
Lambda exonucleation. They are described in the order
of execution by our protocol.
Phosphorylation. Phosphorylation of all PCR primers
used by the recursive construction protocol is performed
beforehand simultaneously, according to the following
protocol: A total of 300pmol of 50 DNA termini in a
50ml reaction containing 70mM Tris–HCl, 10mM
MgCl2, 7mM dithiothreitol, pH 7.6 at 378C, 1mM
ATP, 10 U T4 polynucleotide kinase (NEB, Ipswich,
MA, USA). Incubation is at 378C for 30min and inactiva-
tion at 658C for 20min.
Overlap extension elongation between two ssDNA
fragments. One to ﬁve Picomoles of 50 DNA termini
of each progenitor in a reaction containing 25mM
TAPS pH 9.3 at 258C, 2mM MgCl2, 50mM KCl, 1mM
b-mercaptoethanol 200mM each of dNTP, 4U Thermo-
Start DNA polymerase (ABgene). Thermal cycling
program is as follows: enzyme activation at 958C for
15min, slow annealing 0.18C/s from 958Ct o6 2 8C and
elongation at 728C for 10min.
PCR amplification of the above elongation product with
two primers, one of which is phosphorylated. A total of
1–0.1fmol template, 10pmol of each primer in a 25ml
reaction containing 25mM TAPS pH 9.3 at 258C, 2mM
MgCl2, 50mM KCl, 1mM b-mercaptoethanol 200mM
each of dNTP, 1.9U AccuSure DNA Polymerase
(BioLINE). Thermal cycling program is: enzyme activa-
tion at 958C for 10min, denaturation 958C, annealing
at Tm of primers, and extension 728C for 1.5min/kb to
be ampliﬁed 20 cycles.
Lambda exonuclease digestion of the above PCR product
to re-generate ssDNA. One to ﬁve Picomoles of 50 phos-
phorylated DNA termini in a reaction containing 25mM
TAPS pH 9.3 at 258C, 2mM MgCl2, 50mM KCl, 1mM
b-mercaptoethanol 5mM 1,4-Dithiothreitol, 5U Lambda
Exonuclease (Epicentre). Thermal cycling program is:
enzyme activation at 378C for 15min, 428C for 2min
and enzyme inactivation at 708C 10min.
RESULTS
We have constructed an error-free 1.8kb molecule from
synthetic unpuriﬁed oligos using recursive synthesis and
error correction with in vitro cloning based on smPCR.
At the same time we followed the exact same procedure
but with traditional in vivo cloning as a control. Our
results show that the smPCR-based procedure is compar-
able to traditional cloning in terms of the ﬁdelity of the
clones. Although the accuracy of in vivo cloning is higher
than smPCR, this has a minor eﬀect on the number of
clones required to obtain an error-free clone for molecules
in several kilo base range. The relatively small diﬀerence in
ﬁdelity is greatly outweighed by the improved time, cost
and throughput oﬀered by the in vitro procedure. We
had to integrate several modiﬁcations into smPCR meth-
odology in order for it to be suitable for de novo DNA
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These included improved primer selection, computational
optimization and experimental calibration of template
concentration, real-time diagnosis of faulty reactions,
avoiding the cloning of heteroduplexes, bar-coding mole-
cules and creating a process with adequate ﬁdelity.
Careful selection of adequateprimers isneededto enable
single molecule amplification
smPCR ampliﬁcation requires extensive cycling (9–12).
This often leads to the ampliﬁcation of nonspeciﬁc
products originating from interaction between the PCR
primers (Figure 2a). This often inhibits the ampliﬁcation
of the single molecule template, typically resulting in either
no ampliﬁcation of the target molecule due to dimer for-
mation or in ampliﬁcation of the primer dimer on top of
the correct PCR product (Figure 2a). Consequently, a
large fraction of the smPCRs performed cannot be used
for synthesis since they did not amplify or have nonspeciﬁc
ampliﬁcation products. This has to be compensated for by
performing more smPCRs than are actually needed for
synthesis. To solve this problem we designed a special
primer for smPCR consisting of a single sequence
Figure 1. Overview—Although de novo DNA synthesis is traditionally performed with in vivo cloning, which is time consuming and labor intensive, it
can, in principle, be performed instead in vitro using a modiﬁed smPCR protocol. (a) Work reported here: Target synthetic molecules are recursively
constructed (5) from oligos and then error-corrected using the new smPCR procedure instead of in vivo cloning. In brief, Preparation of the target DNA
molecules for smPCR ampliﬁcation is carried out by a PCR that introduces sites for the smPCR primer (see text). This PCR is stopped at the exponential
phase of ampliﬁcation so that heterodimers are not formed (see text). The PCR products are then diluted according to calculations and experimental
results (see text) and used as template for smPCR with a special primer (C–A primer) that doesn’t produce nonspeciﬁc ampliﬁcation products (see text).
The DNA ‘clones’ ampliﬁed using smPCR are then sequenced and an error-correction process (5) (Also see Supplementary Data Methods section
for error-correction description) is carried out using the smPCR ampliﬁed molecules as starting material until an error free molecule is obtained.
(b) Conceptual illustration of how the smPCR procedure could also be used in principle, with a two-step assembly PCR. From left to right, oligos
are assembled in groups and ampliﬁed to yield fragments 400–500bp long. These could be cloned using exactly the same smPCR procedure described
in this work and sequenced. The error-free clones are then selected for further assembly of the target sequence using various methodologies.
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plate), which contains a sequence of cytosine and adenine
DNA bases only (see Supplementary Data for sequence).
We reasoned that this should reduce the formation of
PCR products that originate from primer-primer interac-
tions due to the noncomplementary nature of the cytosine
and adenine bases. This successfully eliminated nonspeci-
ﬁc ampliﬁcation resulting from interaction between
primers and its inhibiting eﬀect on single molecule ampli-
ﬁcation (Figure 2b), which in turn signiﬁcantly decreased
the total number of PCRs needed to obtain the minimal
number of smPCR clones required for synthesis of error-
free DNA. The sites for the C–A primer (as well as the
random bar coding bases to be discussed later on) at the
termini of the target molecules are incorporated by either
an a priori PCR (16) or during the synthesis of the mole-
cule as part of the target sequence.
Computational optimization andexperimental calibration
oftemplate DNA concentration
smPCR reactions are generally similar to regular PCR
reactions in their basic biochemistry, the diﬀerence is
that while PCR typically start the ampliﬁcation with mul-
tiple copies of the template molecule, the goal in smPCR is
to amplify a single template molecule. This is achieved by
diluting a solution with template molecules in a known
concentration so that the template aliquot is expected to
have about one molecule. As the dilution is a stochastic
process, at any such dilution some aliquots would have
no template molecule and some would have multiple
template molecules. As these two cases cannot be avoided,
smPCR is done as a batch of multiple parallel reactions,
with the hope that at least some would be true smPCRs,
namely successful PCR reactions that amplify single tem-
plate molecules. ‘False positive’ smPCRs, which amplify
multiple template molecules, are identiﬁed using sequenc-
ing (Figure 3 and Supplementary Figure 6). The cost
of sequencing is a major component of synthetic DNA
synthesis, and the sequencing of false positives can
render smPCR unpractical if their fraction in the total
number of reactions is too high. Standard gel/capillary
electrophoreses (CE)/RT-PCR analyses can be used to
diﬀerentiate no template (negative) reactions from (posi-
tive) PCRs with template, however, they cannot be used to
diﬀerentiate a true smPCR from false positive reactions.
Diluting the template to one molecule per well on average
maximizes the fraction of true smPCRs out of all the reac-
tions in the batch (Supplementary Figure 3a, blue plot).
However, it does not maximize the ratio of true smPCRs to
false positives (Supplementary Figure 3a, green plot) which
is important for avoiding futile sequencing. For example,
aiming for one molecule per well on average leads to >50%
futile sequencing of false positives (Supplementary
Figure 3a, green plot). Further reducing template concen-
tration reduces the extent of futile sequencing of PCRs
with multiple template molecules, however, it increases
the extent of futile PCRs due to no template reactions.
Determining the template concentration that would
result in an optimal ratio between true smPCRs, false posi-
tives and no template reactions can only be determined by
Figure 2. Primer, dimers and anticipation. Adequate selection of primers leads to improved speciﬁcity in smPCR; RT-PCR can distinguish true
smPCRs from false positives. (a) smPCRs with regular primers show many nonspeciﬁc ampliﬁcation products. Top gel: Lanes 1–7: positive control
(many template molecules) PCRs show bands at the correct size. Lanes 8–15: no-template control PCRs have nonspeciﬁc ampliﬁcation from primers.
Bottom gel: smPCR experiments—a large fraction of reactions show nonspeciﬁc ampliﬁcation from primers which inhibit smPCR and hinder its use.
(b) smPCRs with the C–A primer shows speciﬁc ampliﬁcation. Top left gel: positive control (multiple template molecules) PCRs show bands at the
correct size. Top right gel: no-template control PCRs do not have nonspeciﬁc ampliﬁcation. Bottom gel: smPCR experiments bands at the correct
size and frequency with no nonspeciﬁc ampliﬁcation C. RT-PCR helps determining whether PCRs are true smPCRs or false positives due to
nonspeciﬁc ampliﬁcation from primers or contamination.
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reactions. We calculated the optimal concentration to be
 0.6 template molecules per smPCR well if an equal cost
is associated with smPCR and sequencing (Supplementary
Figure 3b), and  0.2 molecules per well if sequencing
is assigned the more realistic cost of eight times that
of smPCR (Supplementary Figure 3c). Performing
smPCRs at the optimal template concentration reduces
the overall cost of obtaining each sequenced true smPCR
and the overall cost of using smPCR with de novo DNA
synthesis since it reduces futile sequencing from 50%
(with 1 molecule/well) to 10% (with  0.2 molecules/well)
(Supplementary Figure 3a). A standard 260nm OD mea-
surement can be used to determine the optimal
concentration.
Even though most of the smPCRs performed using 0.2
molecules/well (i.e. 80% of reactions having no template),
these no-template PCRs are easily identiﬁed and dis-
tinguished from ‘true’ smPCRs, and their sequencing
is avoided. Additionally, the cost of no template PCRs
is further diminished by performing the reactions in
very low volume (down to 2ml in standard liquid
handling robots). We also found that RT-PCR can be
used to accurately determine the dilution required to
dilute the template to the calculated optimal concentration
(0.2 molecules/well). A one-time calibration (see Supple-
mentary Data Methods for description) allows the routine
use of RT-PCR to determine the dilution required before
each smPCR experiment. This strategy proved as accurate
and as robust as performing the dilution according to a
260nm OD measurement and was used throughout the
work presented in this paper.
RT-PCR facilitatesthe diagnosis of faultyreactions
We used RT-PCR to conﬁrm that the eﬃciency at which
ourC–AprimerampliﬁesDNAiscloseto100%.Giventhis
eﬃciency, we predict the number of PCR cycles required
to reach PCR ampliﬁcation saturation from the initial
and typical ﬁnal template concentrations (Supplementary
Figure 4, green plot). Our RT-smPCR results conﬁrm that
this prediction is accurate all the way down to single mole-
cule ampliﬁcation, which displays an ampliﬁcation curve
that is detectable from approximately cycle 32 and satu-
rates after  42 cycles (Figure 2c and Supplementary
Figure 3. Heterodimers hinder smPCR. The template for smPCR is produced with an ordinary PCR reaction. If this PCR is not not terminated at
the exponential phase of ampliﬁcation it produces heterodimers, which hinder smPCR. (a) Overcycling of the PCR past the exponential phase of
ampliﬁcation leads to the formation of hetero-dimers by re-annealing of diﬀerent elongated strands. (b) The sequencing chromatograms of both sense
and antisense strands of a PCR ampliﬁed heterodimer are frame-shifted and unreadable from the site of the (insertion or deletion) mutation and on.
(c) A PCR terminated before the end of the exponential ampliﬁcation generates homodimers, not heterodimers. (d) The sequencing chromatogram of
a PCR ampliﬁed homodimer is readable and not frame-shifted even if a mutations (with respect to the target sequence) are present.
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mination of whether PCRs are true smPCRs or false posi-
tives (e.g. contaminated, actually had many template
molecules or primer dimers) since they do not exhibit a
typical ampliﬁcation curve which indicates single molecule
ampliﬁcation (Figure 2c), eschewing their further analysis.
Heteroduplexes prevent invitro cloning ofsynthetic DNA
Initially, the sequencing of all our true smPCR experiments
resulted in shifted sequencing chromatograms which could
not be read properly, despite the fact that in vivo clones
from the same DNA sequenced ﬁne. The cause of this
turned out to be that de novo constructed DNA is double
stranded (1–4,6,7), with each strand having diﬀerent
errors originating from diﬀerent synthetic oligo species.
Performing smPCR on such a heteroduplex creates two
distinct populations of ampliﬁed molecules, one from
each strand. The abundance of deletions and insertions
in synthetic oligos (4,15) causes the sequencing chromato-
grams of these dual population PCRs to be frame shifted
and their sequence cannot be determined (Figure 3b).
These smPCR cloning results were reinforced by cal-
culations that show that, according to the error-rate of
oligos (4,15), heteroduplexes are much more abun-
dant than homoduplexes at the typical cloning length
(Supplementary Figure 5). In practice almost all synthetic
clones were heteroduplexes (due to insertions or deletions)
which could not be sequenced properly. Rare exceptions
were clones that were heteroduplexes only due to substitu-
tions in one or both strands (which do not result in frame-
shifts) (Supplementary Figure 6) and were therefore
sequenced properly.
The reason that heteroduplexes were not reported to be
a problem so far in de novo synthesis (1–4,6,7) is probably
the ubiquitous use of in vivo cloning, which converts
the erroneous mismatched DNA into perfectly matched
DNA, albeit erroneous compared to the target sequence.
A true smPCR should therefore be performed on either
one ssDNA molecule or on two perfectly complemented
molecules, i.e. one homoduplex dsDNA. Initially we
treated synthetic dsDNA constructs labeled with a 50
phosphate at one end with Lambda exonuclease to con-
vert them into ssDNA. smPCR on ssDNA templates
generated by this enzymatic treatment indeed resulted in
a larger fraction of smPCRs which can be sequenced.
However, a complete and simpler solution to this problem
was achieved not by generating ssDNA but by generating
homoduplex dsDNA. Homoduplex dsDNA was gener-
ated by terminating the PCR ampliﬁcation of synthetic
DNA prematurely, not allowing it past the exponen-
tial phase of ampliﬁcation, as monitored by RT-PCR
(Figure 3c). Terminating the PCR at the exponential
phase of ampliﬁcation assures that each dsDNA molecule
is formed by primer-directed polymerization which forms
homoduplexes (Figure 3d and Supplementary Figure 5,
primer directed polymerization plot), and not by the
annealing of previously elongated strands which forms
heteroduplexes (Figure 3b and Supplementary Figure 5,
annealing plot). A comparison between smPCRs exe-
cuted using templates generated by primer-directed
polymerization and by annealing of previously elongated
strands are shown in Figure 3c and d, and Figure 3a and
b, respectively.
Single-molecule verification withrandom oligos
To facilitate the simple identiﬁcation of rare smPCRs that
despite the measures reported above were still not per-
formed on single molecules, we integrated another feature
in our procedure, previously proposed for other smPCR
applications (16). We incorporated oligos with three
random bases at both ends of the synthetic DNA con-
structs that are to be cloned, eﬀectively bar-coding the
molecules with a four-letter code at six positions
(4
6=4096 tags) (Figure 4a). Sequencing these molecules
show that the sequence at the location of the random bases
is always singular in the sequencing of a true smPCR
(Figure 4d) and multiple in PCRs performed on >1
template molecules (Figure 4c).
Fidelity of single molecule amplification
Errors produced by smPCR pose a minor problem
in sequencing and genotyping applications since they
can only produce artifacts if inserted during the ﬁrst
few rounds of ampliﬁcation (11). Errors inserted after
the ﬁrst few cycles (i.e. the remaining  36–37 cycles)
are represented in a low fraction of the population
(Supplementary Figure 7) and are not detectable by
sequencing. Nevertheless, errors are inserted during
all cycles of smPCR at a ﬁxed rate (Supplementary
Figure 8). Although this hardly aﬀects DNA reading
applications (11) (Supplementary Figure 7) it dramatically
aﬀects DNA writing using smPCR since the smPCR
ampliﬁed molecules are used as building blocks for fur-
ther synthesis. Using a standard Taq polymerase with
an error-rate of 1/8000 (17) to amplify single error-free
DNA molecules results in ampliﬁed copies that have an
average error rate of 1/200 compared to the original
sequence after the 40 PCR cycles required for single mole-
cule ampliﬁcation (Supplementary Figure 8). This linear
increase of error-rate with polymerase cycling results in an
exponential increase in the number of clones that have
to be sequenced in order to obtain an exact copy of a
template molecule 1kb long (Supplementary Figure 9).
We initially recursively constructed and error corrected
(Figure 1a for overview of procedure) the 800-bp long
DNA coding for the GFP from synthetic unpuriﬁed
oligos using our smPCR-based procedure with a Taq
DNA polymerase. The clones produced from the uncor-
rected GFP constructs were sequenced and had an error
rate of 1/129 (Supplementary Table 1). Only error-free
fragments from them were used for the reconstruction of
the full-length molecule. The error rate of full-length error
corrected GFP molecules (after reconstruction) with the
smPCR procedure was determined by traditional cloning
of the error corrected molecules into Escherichia coli
and sequencing. The results were poor, as expected,
reﬂecting an error-rate of 1/215 (Supplementary Table 2)
and no error-free GFP molecules were found among the
12 clones, reinforcing our calculations (Supplementary
Figures 8 and 9, respectively). The error-corrected clones
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even though the segments used for their reconstruction
were error-free. These segments seemed error free in the
sequencing of smPCR clones since most of the errors
inserted during smPCR ampliﬁcation (i.e. approximately
during the last 37 of the 40 cycles required) are invisible in
the sequencing chromatogram (Supplementary Figure 7).
To make sure the errors originated from smPCR and
not from the oligos we repeated the exact same error-
correction procedure using traditional in vivo cloning of
the GFP fragments into E. coli instead of smPCR. As with
the smPCR procedure, error-free segments were chosen
and used for reconstruction of the target GFP molecule.
This control procedure yielded error-free GFP molecules
out of almost every clone (Supplementary Table 2).
Therefore, the entire procedure using Taq is noneﬀec-
tive for de novo DNA synthesis since the error-rate result-
ing from smPCR ampliﬁcation is roughly the error-rate of
the synthetic molecules before any error-correction.
Moreover, error-correction using smPCR with Taq may
even increase the number of clones needed compared to
construction with no error-correction, depending on the
error-rate of the oligos used (Figure 5c, dark blue and
green plots).
Nevertheless, technically the procedure was successful
(i.e. there were no frame-shifting heteroduplexes, properly
calculated limiting dilution, no primer–dimer problems,
etc.), indicating that the remaining diﬃculty is indeed
the error rate of the polymerase.
Denovo synthesis ofa1.8-kb mitochondrial DNA using
thesmPCR procedure
We set out to test the procedure using Accusure, a more
accurate (proof-reading) DNA polymerase (Materials and
Methods). This time we also attempted to construct a
longer synthetic construct 1.8kb long, since a fragment
of this length would demonstrate that the procedure can
be used for the complete in vitro synthesis and error cor-
rection of most synthetic genes. Its synthesis and error
correction was conducted as a comparative analysis
Figure 4. Randomized primers. (a) Primers with random bases are inserted into the termini of the molecules by PCR and the reaction is terminated
at the exponential phase to avoid hetero-dimers. (b) DNA molecules from the light green PCR shown in panel A are diluted and used as template for
smPCR with the C–A primer (PCRs on single molecules). As control a ‘false positive’ smPCR with the same DNA but with many template molecules
was also performed. (c) On the left: the sequencing chromatogram of the ‘false positive’ smPCR from panel b shows al 4 bases at the 3 random
positions, indicating that the reaction was not a true smPCR. On the right: the sequencing chromatograms of four diﬀerent smPCRs from panel B
show only one base call at each of the three random positions, indicating they were true smPCRs.
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in vivo cloning-based procedure.
We constructed the molecule from unpuriﬁed oligos up
to the cloning phase (Supplementary Figure 10) and then
split the error-correction process into two separate and
parallel courses executed side-by-side using the same start-
ing material, one with smPCR and the other with in vivo
cloning. Clones generated by both methods before error-
correction were sequenced and their error-rate was the
same (Supplementary Tables 3 and 4), as expected, reﬂect-
ing the error-rate of the synthetic oligos used in synthesis
(4,15). We identiﬁed the same set of error-free of segments
(i.e. the minimal cut, see Supplementary Data Methods
section for deﬁnition) in both sets of clones and used
them to reconstruct the target 1.8-kb molecule twice,
once from each set of clones (Supplementary Figures 11
and 12) and using the exact same protocol for reconstruc-
tion. Once reconstructed from error-free segments, the
two 1.8-kb synthetic constructs were cloned into E. coli
and sequenced in order to evaluate their error-rate. Target
constructs from the smPCR procedure had an error-rate
of 1/1128 (Supplementary Table 6) (we have no reference
to compare this with as the Accusure error-rate is not
known), giving a  6-fold improvement compared to the
same procedure using Taq polymerase (see GFP results)
and to the error-rate of initial uncorrected synthetic
DNA. Error-free synthetic 1.8-kb target molecules were
easily obtained from a small number of clones with this
improved error-rate (Figure 5, red plot). The control
in vivo cloning procedure also yielded error-free clones at
an error-rate of 1/2193 (Supplementary Table 5).
The 1/1128 error-rate obtained using a proof-reading
enzyme for the smPCR-procedure is suﬃcient for the syn-
thesis of most genes with a reasonable number of clones
(see Figure 5c, green plot). This error-rate is a result of
two factors, namely the errors inserted during smPCR
ampliﬁcation and errors inserted during the PCR ampli-
ﬁcations required for the reconstruction process. The
1/2193 error rate obtained from error correction using
traditional cloning is most probably largely due to the
errors inserted during the PCR ampliﬁcations required
for reconstruction since in vivo ampliﬁcation of DNA is
very accurate. Although the overall error rate of the pro-
cedure using in vivo cloning is better than with the in vitro
cloning presented here, this  2-fold diﬀerence in error
rates only slightly aﬀects the number of clones required
for obtaining error-free synthetic molecules of most genes
(Figure 5c, light blue and red plots). In general, the prob-
ability that a given synthesis process yields error-free
molecules largely depends on the number of clones that
are sequenced. For example, even synthesis without error
correction can, in principle, produce error-free clones
with high probability if a very large number of clones
are screened (Supplementary Figure 2, blue and green
plots). Conversely, the same process is unlikely to produce
error-free molecules if a small number of clones are
screened (Supplementary Figure 2, blue and green plots).
Therefore, it is useful to describe for diﬀerent synthesis
methods how the number of sequenced clones inﬂuences
the probability of obtaining error-free clones and,
more practically, vice versa, how the required probability
Figure 5. Error-free molecules are readily cloned using smPCR. smPCR
provides an alternative to in vivo cloning in de novo DNA synthesis up to
the 2 Kb range at least. (a) For a 1-kb molecule and (b) for a 2-kb
molecule show the probability that at least one of the molecules after
error correction is error-free as a function of the number of molecules
screened: blue plot—no error-correction or error-correction with smPCR
using Taq (error-rate 1/200); green plot—error-correction with smPCR
using a proofreading polymerase; red plot—error-correction with in vivo
cloning. (c) The total (including clones of construction) number of
clones needed for the construction of at least one error-free molecule
with 90% probability as a function of the length of the molecule.
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the number of clones that one should sequence
(Figure 5a and b). We aimed at designing a process that
yields error-free clones with high probability. Our results
show that even with high success requirements (90% prob-
ability) the diﬀerence between our smPCR procedure and
traditional cloning is negligible up to the 2-kb range at
least (Figure 5a and b). For example, ﬁnding error-free
fragments after error correction 1kb and 2kb long with
probability of at least 90% requires only 4 and 8 clones
respectively after using our smPCR method compared to 2
and 3 clones after using in vivo cloning (Figure 5a and b).
DISCUSSION
Our results show that, even though smPCR has typically
been used in DNA reading applications to date (11–14),
by following the procedures outlined in this work it can
also be used for the typically cloning intensive de novo
DNA writing (3–9). We demonstrated for the ﬁrst time
a general method for the synthesis of long synthetic frag-
ments from unpuriﬁed oligos completely in vitro. The
entire method as reported here is highly accessible to
every lab since it is performed using oﬀ-the-shelf reagents,
standard lab equipment and requires no special expertise.
In this report we show that the total construction and
error correction of synthetic error free fragments of at
least  2kb can be made from a small number of clones
using our in vitro method and that these results are
comparable to construction using traditional in vivo
cloning (Figure 5c, red and light blue plots). The use of
other thermostable enzymes with improved ﬁdelity (18)
is expected to enable synthesis of even larger synthetic
DNA molecules using the same procedure and is a subject
of current work. Alternatives to high ﬁdelity DNA ampli-
ﬁcation with thermostable polymerases, for example
mesophilic ampliﬁcation based on the isothermal strand
displacement polymerization activity of the phi29 poly-
merase may also be considered in the future. The phi29
polymerase, already shown to be useful in the ampliﬁ-
cation of single DNA molecules (19) is comparable in
accuracy to high ﬁdelity thermostable polymerases (20),
however its integration into a DNA synthesis scheme is
not straightforward.
Although, in this report we have demonstrated the inte-
gration of in vitro cloning based on smPCR with a speciﬁc
DNA synthesis method (5), it is conceivable that it can be
used as an alternative to the cloning phase of other DNA
synthesis methods as well (Figure 1b) and for the cloning
of synthetic DNA in general. Cloning of synthetic DNA
molecules using smPCR is more rapid ( 3h), it is ame-
nable to automation (using standard liquid handling
robots) and scalable (using 96- or 384-well PCR plates),
whereas traditional cloning is time consuming ( 1–2
days), manual labor intensive and diﬃcult to automate.
A major requirement for automated DNA synthesis is
robustness and reproducibility. Our experience with per-
forming PCR directly on colonies is that it is not as robust
and reproducible as traditional production and puriﬁca-
tion of plasmids. Additionally, although automated
colony picking does exist it requires relatively expensive
specialty equipment, while the process reported in this
manuscript only requires standard lab equipment and
turned out to be a highly robust and reproducible process.
Furthermore, automation of traditional cloning doesn’t
sum up to only automated colony picking. It also requires
inoculation of bacteria in sterile conditions into a Petri
dish and overnight growing of colonies. These are diﬃcult
to automate and time consuming, respectively. It should
be noted that automated colony picking may be substi-
tuted by in vivo cloning-by-dilution, but this may hold
diﬃculties of its own such as the absence of selection for
blue/white colonies which helps avoid futile sequencing.
In any case, all this is preceded by the process of insert-
ing DNA into cells (the transformation itself) which may
be performed in 96-well electroporation devices or by
heat shock but usually requires some manual labor and
is not easily performed in an automated robotic setup. The
new procedure described here does not require the use of
cells of any kind and therefore reduces potential bioha-
zards associated with replicating speciﬁc DNA fragments
in vivo, with overusing antibiotic resistance for cloning and
allows processing of fragments that are diﬃcult to repli-
cate in vivo.
Although this is a proof of concept paper, intended only
to demonstrate the feasibility of using smPCR for de novo
DNA synthesis, the amenability of the method for scaling-
up is apparent. Therefore, we reason that its simplicity,
rapidness and amenability to automation make it a pos-
sible alternative to traditional cloning practice in DNA
synthesis.
Combining the in vitro synthetic DNA cloning and
sequencing methodology reported here with our previously
published automated construction and error correction
method (5) has been straightforward. In the future we
hope to mange to apply these methodologies to construct
DNA originating from high-throughput synthesis on chips
(4). Such capabilities should, in turn, facilitate ever more
ambitious synthetic biology eﬀorts involving the synthesis
of synthetic DNA.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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